MarginsXMarginsX
Home › Markets › Health Care › RGC

Regencell Bioscience Holdings Limited (RGC)

RGC trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.72
-4.45% on the day
Market cap
$2.3B
Mid cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerRGC on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryHong Kong
IPO year2021
SEC CIK0001829667
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inCayman Islands

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
22.1 months
$14.2M cash at June 30, 2026
Share count, 1 year
+0.3%
2025-06-30 to 2026-06-30 · +0.3% over 3 years
Going-concern doubt
Yes
20-F filed October 7, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
20-F 2026-10-07
Cash and burn$14.2M cash; operating cash flow -$1.9M a quarter.Report 2026-06-30
Shares outstanding495,884,376 (2026-06-30); 494,488,908 a year earlier; 13,012,866 three years earlier. 3y figure adjusted for split (38-for-1 overall).Cover page 2026-06-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-05-19
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHTL International, LLC, Houston, Texas, United StatesPCAOB Form AP 2026-10-08
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-06-30
Not filed-$11.7M-$7.7M$14.2MNo debt tagsNeeds four quarters20-F 2026-10-07
FY 2025
2025-06-30
Not filed-$3.6M-$3.1M$2.4MNo debt tagsNeeds four quarters20-F 2026-10-07
FY 2024
2024-06-30
Not filed-$4.3M-$4.0M$3.0MNo debt tagsNeeds four quarters20-F 2026-10-07
FY 2023
2023-06-30
Not filed-$5.9M-$5.0M$1.6M$11KNeeds four quarters20-F 2025-10-31
FY 2022
2022-06-30
Not filed-$7.4M-$5.3M$6.4M$16KNeeds four quarters20-F 2024-10-25
FY 2021
2021-06-30
Not filed-$1.3M-$767K$59K$3.7MNeeds four quarters20-F 2023-10-27
FY 2020
2020-06-30
Not filed-$812K-$727K$387K$3.1MNeeds four quarters20-F 2021-10-29
FY 2019
2019-06-30
Not filed-$391K-$391K$243KNo debt tagsNeeds four quarters20-F 2021-10-29

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-05-19
Latest annual report
ANNUAL REPORT
20-F2026-10-07
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-05-22

Source: SEC EDGAR submissions feed, 86 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.3%
1 month-39.7%
3 months-5.7%
Year to date-76.5%
1 year-62.0%
From 52-week high-90.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.33-5.23%$2.0B
RLXRLX Technology Inc.$1.53-1.92%$1.9B
DFTXDefinium Therapeutics Inc. Common Shares$30.16-5.99%$4.1B
CRONCronos Group Inc. Common Share$3.27-3.25%$1.2B
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier